Results 81 to 90 of about 70,027 (183)

The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk

Scientific Reports
Early on in the COVID-19 pandemic, we aimed to assess the effectiveness of hydroxychloroquine on reducing the need for hospital admission in patients in the community at higher risk of complications from COVID-19 syndromic illness (testing was largely ...
F. D. Richard Hobbs, Jienchi Dorward, Gail Hayward, Ly-Mee Yu, Benjamin R. Saville, Christopher C. Butler, the PRINCIPLE Investigators   +6 more
doaj   +1 more source

Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study

, 2015
Marilita M Moschos,1 Eirini Nitoda,1 Irini P Chatziralli,1 Zisis Gatzioufas,2 Chryssanthi Koutsandrea,1 George Kitsos3 1First Department of Ophthalmology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 2Swiss Eye ...
Gatzioufas Z, Koutsandrea C, Kitsos G, Moschos MM, Chatziralli IP, Nitoda E   +5 more
core  

Geopolitical associations of hydroxychloroquine and chloroquine prescriptions during COVID-19

, 2020
With the onset of the COVID-19 pandemic, scientists, medical providers, and policymakers across the globe scrambled to find both prophylactic and therapeutic treatments for the novel coronavirus.
Ryan McDevitt, Peter A. Ubel, Farrah Madanay   +2 more
core   +1 more source

Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. [PDF]

, 2020
Objectives: To determine the efficacy of Hydroxychloroquine vs. Hydroxychloroquine + Nitazoxanide in reducing the need for invasive mechanical ventilatory support for patients with COVID-19.
Meneses Calderón, José, Mendieta Zerón, Hugo; 45175, Padmanabhan, Srivatsan;#, Meneses Calderón, José;#, Padmanabhan, Srivatsan, Mendieta Zerón, Hugo   +5 more
core  

Carvacrol Protect Hippocampal Neurons Against Hydroxychloroquine-induced Damage: in vitro Study

, 2023
The use of hydroxychloroquine, an antimalarial drug, in the treatment of Covid-19 disease, which has turned into a worldwide epidemic, was initially viewed positively.
Yılmaz, Ayşegül, Çiçek, Betül, Isık, Mesut, Necip, Adem, Tgzd, Ali.tgzd, Hacımüftüoğlu, Ahmet   +5 more
core   +1 more source

Hydroxychloroquine Retinopathy

This powerpoint reviews hydroxychloroquine retinopathy including the clinical findings and the updated American Academy of Ophthalmology screening guidelines (revised in 2016).
Zoe Rebecca Williams, MD; David Allen DiLoreto Jr., MD
core  

Plasma-Protein Binding of the Enantiomers of Hydroxychloroquine and Metabolites

, 1993
The in vitro binding of the enantiomers of hydroxychloroquine and its three major metabolites in pooled plasma obtained from four healthy volunteers and the binding of the enantiomers of hydroxychloroquine to purified plasma proteins has been ...
Tett, SE, McLachlan, AJ, Cutler, DJ
core   +1 more source

Response to hydroxychloroquine in discoid lupus erythematosus

, 2011
Discoid Lupus Erythematosus (DLE) is the most common form of cutaneous lupus and causes irreversible facial scarring and disfigurement. Hydroxychloroquine is the oral therapy of choice.
Wahie, Shyamal
core  

Screening and management of hydroxychloroquine retinopathy

, 2018
Hydroxychloroquine is a drug increasingly used in the treatment of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune disorders.
Lotery, Andrew
core   +1 more source

Hydroxychloroquine and Chloroquine

Clinical Infectious Diseases, 2020
openaire   +2 more sources